- Home
- SANA vs KOD Comparison
SANA vs KOD Comparison
Compare SANA & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANA
- KOD
- Stock Information
- Founded
- SANA 2018
- KOD 2009
- Country
- SANA United States
- KOD United States
- Employees
- SANA N/A
- KOD N/A
- Industry
- SANA Medicinal Chemicals and Botanical Products
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SANA Health Care
- KOD Health Care
- Exchange
- SANA Nasdaq
- KOD Nasdaq
- Market Cap
- SANA 522.4M
- KOD 454.7M
- IPO Year
- SANA 2021
- KOD 2018
- Fundamental
- Price
- SANA $3.01
- KOD $4.45
- Analyst Decision
- SANA Strong Buy
- KOD Hold
- Analyst Count
- SANA 4
- KOD 4
- Target Price
- SANA $13.00
- KOD $8.00
- AVG Volume (30 Days)
- SANA 3.3M
- KOD 342.4K
- Earning Date
- SANA 02-27-2025
- KOD 03-27-2025
- Dividend Yield
- SANA N/A
- KOD N/A
- EPS Growth
- SANA N/A
- KOD N/A
- EPS
- SANA N/A
- KOD N/A
- Revenue
- SANA N/A
- KOD N/A
- Revenue This Year
- SANA N/A
- KOD N/A
- Revenue Next Year
- SANA N/A
- KOD N/A
- P/E Ratio
- SANA N/A
- KOD N/A
- Revenue Growth
- SANA N/A
- KOD N/A
- 52 Week Low
- SANA $1.52
- KOD $2.19
- 52 Week High
- SANA $12.00
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- SANA 50.21
- KOD 27.56
- Support Level
- SANA $3.00
- KOD $4.85
- Resistance Level
- SANA $3.35
- KOD $5.53
- Average True Range (ATR)
- SANA 0.24
- KOD 0.39
- MACD
- SANA -0.03
- KOD -0.05
- Stochastic Oscillator
- SANA 50.57
- KOD 1.03
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.